Pfizer Limited Total Assets

Latest as of March 2026: Rs49.22 Billion INR ≈ $532.28 Million USD

Pfizer Limited total assets. Based on the latest financial reports, Pfizer Limited (PFIZER) holds total assets worth Rs49.22 Billion INR (≈ $532.28 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Pfizer Limited market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Pfizer Limited (2005–2026)

Total assets of Pfizer Limited from 2005 to 2026. This chart illustrates how Pfizer Limited's total assets have evolved over time, based on quarterly financial data. See PFIZER live share price for real-time trading data and today's change.

Pfizer Limited - Asset Composition Analysis

Pfizer Limited Total Assets Breakdown (March 2026)

Pfizer Limited total assets breakdown as of March 2026. Pfizer Limited's total assets of Rs49.22 Billion consist of 77.3% current assets and 22.7% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	2.1%
Accounts Receivable	Rs1.82 Billion	3.7%
Inventory	Rs4.73 Billion	9.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs143.50 Million	0.3%
Goodwill	Rs5.27 Billion	10.7%

Asset Composition Trend (2005–2026)

This chart illustrates how Pfizer Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Pfizer Limited current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Pfizer Limited's current assets represent 77.3% of total assets in 2026, an increase from 72.8% in 2005.
Cash Position: Cash and equivalents constituted 2.1% of total assets in 2026, down from 30.9% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 26.0% in 2005.
Asset Diversification: The largest asset category is goodwill at 10.7% of total assets.

Pfizer Limited Competitors by Total Assets

Key competitors of Pfizer Limited based on total assets are shown below.

Company	Country	Total Assets
Merck & Company Inc NYSE:MRK	USA	$129.80 Billion
AstraZeneca PLC NASDAQ:AZN	USA	$114.02 Billion
Pfizer Inc SA:PFIZ34	Brazil	R$201.13 Billion
Cosmo Pharmaceuticals N.V F:C43	Germany	€612.64 Million
Zhejiang Int'L Group Co Ltd SHE:000411	China	CN¥17.31 Billion
Eli Lilly and Company SA:LILY34	Brazil	R$116.58 Billion
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Brazil	R$3.71 Billion
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	China	CN¥18.38 Billion

Pfizer Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	6.06	6.17	2.49
Quick Ratio	5.31	5.33	1.91
Cash Ratio	0.00	4.92	0.00
Working Capital	Rs31.76 Billion	Rs29.43 Billion	Rs11.50 Billion

Pfizer Limited - Advanced Valuation Insights

This section examines the relationship between Pfizer Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.00
Latest Market Cap to Assets Ratio	0.04
Asset Growth Rate (YoY)	0.2%
Total Assets	Rs49.22 Billion
Market Capitalization	$1.89 Billion USD

Valuation Analysis

Below Book Valuation: The market values Pfizer Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Pfizer Limited's assets grew by 0.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Pfizer Limited (2005–2026)

The table below shows the annual total assets of Pfizer Limited from 2005 to 2026.

Year	Total Assets	Change
2026-03-31	Rs49.22 Billion ≈ $532.28 Million	+0.22%
2025-03-31	Rs49.11 Billion ≈ $531.12 Million	+16.14%
2024-03-31	Rs42.29 Billion ≈ $457.33 Million	+5.70%
2023-03-31	Rs40.01 Billion ≈ $432.66 Million	+2.57%
2022-03-31	Rs39.01 Billion ≈ $421.83 Million	+19.43%
2021-03-31	Rs32.66 Billion ≈ $353.19 Million	-25.87%
2020-03-31	Rs44.05 Billion ≈ $476.43 Million	+11.81%
2019-03-31	Rs39.40 Billion ≈ $426.09 Million	+6.78%
2018-03-31	Rs36.90 Billion ≈ $399.06 Million	+12.82%
2017-03-31	Rs32.71 Billion ≈ $353.71 Million	+12.25%
2016-03-31	Rs29.14 Billion ≈ $315.11 Million	+11.57%
2015-03-31	Rs26.12 Billion ≈ $282.43 Million	+182.53%
2014-03-31	Rs9.24 Billion ≈ $99.96 Million	-55.12%
2013-03-31	Rs20.60 Billion ≈ $222.73 Million	+30.64%
2012-03-31	Rs15.76 Billion ≈ $170.49 Million	+13.72%
2011-03-31	Rs13.86 Billion ≈ $149.92 Million	+15.20%
2010-03-31	Rs12.03 Billion ≈ $130.14 Million	+9.63%
2009-03-31	Rs10.98 Billion ≈ $118.71 Million	+26.53%
2008-03-31	Rs8.67 Billion ≈ $93.81 Million	+34.18%
2007-03-31	Rs6.47 Billion ≈ $69.92 Million	+12.23%
2006-03-31	Rs5.76 Billion ≈ $62.30 Million	+10.32%
2005-03-31	Rs5.22 Billion ≈ $56.47 Million	--

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General

Market Cap

$1.89 Billion

Rs174.83 Billion INR

Market Cap Rank

#6110 Global

#276 in India

Share Price

Rs3821.60

Change (1 day)

+5.03%

52-Week Range

Rs3612.30 - Rs5197.80

All Time High

Rs6318.30